Industry › BioTech

Press Releases

校正来源：Solta Medical的Thermage(R) FLX和TR-4回流垫在中国获得注册认证

Jan 23, 2024 08:23 HKT/SGT

CORRECTION BY SOURCE: Solta Medical's Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China

Jan 23, 2024 08:00 HKT/SGT

The 2024 TIENS Global Business Launch Conference Provides a Grand Opening

Jan 19, 2024 11:00 HKT/SGT

Envision Pharma Group Welcomes Industry Veteran and HR Expert Carolyn Bartholdson as Chief People Officer

Jan 18, 2024 20:00 HKT/SGT

Eisai: Antiepileptic Drug Fycompa Injection Formulation Approved in Japan

Jan 18, 2024 14:12 HKT/SGT

Chiron AS Establishes State-of-the-Art Research Centre in Trondheim, Norway, Advancing Environmental Surveillance

Jan 17, 2024 22:00 HKT/SGT

Eisai Listed as a Global 100 Most Sustainable Corporation for the Eighth Time

Jan 17, 2024 16:08 HKT/SGT

Revolutionizing Drug Development: Novigenix Unveils AI-Powered RNA Analysis for Immune Response Profiling

Jan 17, 2024 15:00 HKT/SGT

최신 분석에 따르면 미국의 바이오테크 기업 중 65%가 적절한 CRO파트너를 식별하는 데 어려움을 겪고 있습니다

Jan 17, 2024 09:00 HKT/SGT

Envision Pharma Group Appoints Life Sciences Industry Veteran Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC)

Jan 16, 2024 20:00 HKT/SGT

最新的分析显示，65%的美国生物技术公司在寻找合适的合同研究机构（CRO）合作伙伴方面面临困难

Jan 16, 2024 19:00 HKT/SGT

最新的分析顯示，65%的美國生技公司在尋找合適的合約研究機構（CRO）合作夥伴方面面臨困難

Jan 16, 2024 19:00 HKT/SGT

Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments

Jan 16, 2024 13:00 HKT/SGT

Eisai Furthers Oncology Research Across Multiple Cancers at ASCO GI and ASCO GU 2024

Jan 16, 2024 09:25 HKT/SGT

エーザイ、ASCO GI および ASCO GU において複数のがんに対する最新の開発研究に関する演題を発表

Jan 16, 2024 09:00 JST

Hyris Fulfils Its Integration Into Ulisse Biomed to Give Birth to a New International Group Ready to Make Its Mark in the Global Biotech Market

Jan 15, 2024 15:00 HKT/SGT

最新の分析によると、米国バイオテック企業の65％が適切なCROパートナーの特定に苦慮

Jan 12, 2024 16:00 JST

Latest Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner

Jan 12, 2024 16:00 HKT/SGT

Eisai: The Scientific Advisory Group (SAG) to Convene to Discuss the Marketing Authorization Application for lecanemab in the EU

Jan 11, 2024 15:33 HKT/SGT

Eisai: "LEQEMBI" (Lecanemab) Approved for the Treatment of Alzheimer's Disease in China

Jan 10, 2024 09:15 HKT/SGT